What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

about

Placenta-Derived Decidua Stromal Cells for Treatment of Severe Acute Graft-Versus-Host Disease.

P2860

Q52658261-FACD6A1E-EDCF-4A10-9343-DAF8EA831E83

P2860

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

Item

http://www.wikidata.org/entity/Q48191465

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

What is the outcome in patient ...... ute graft-versus-host disease?

@en

What is the outcome in patient ...... ute graft-versus-host disease?

@nl

type

Item

label

What is the outcome in patient ...... ute graft-versus-host disease?

@en

What is the outcome in patient ...... ute graft-versus-host disease?

@nl

prefLabel

What is the outcome in patient ...... ute graft-versus-host disease?

@en

What is the outcome in patient ...... ute graft-versus-host disease?

@nl

P1476

What is the outcome in patient ...... ute graft-versus-host disease?

@en

P2093

A Ganser

http://www.w3.org/2001/XMLSchema#string

A Ghavamzadeh

http://www.w3.org/2001/XMLSchema#string

A Mailhol

http://www.w3.org/2001/XMLSchema#string

A Nagler

http://www.w3.org/2001/XMLSchema#string

C Schmid

http://www.w3.org/2001/XMLSchema#string

D Beelen

http://www.w3.org/2001/XMLSchema#string

G Ehninger

http://www.w3.org/2001/XMLSchema#string

G Socié

http://www.w3.org/2001/XMLSchema#string

G Stuhler

http://www.w3.org/2001/XMLSchema#string

J Finke

http://www.w3.org/2001/XMLSchema#string

P2860

Secondary treatment of acute graft-versus-host disease: a critical review

Pentostatin in steroid-refractory acute graft-versus-host disease

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute Graft-versus-Host Disease in Pediatric Hematopoietic Stem Cell Transplant Patients.

The biology of graft-versus-host disease: experimental systems instructing clinical practice.

Vedolizumab as induction and maintenance therapy for Crohn's disease.

Reduced mortality after allogeneic hematopoietic-cell transplantation.

Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial.

Blockade of lymphocyte chemotaxis in visceral graft-versus-host disease.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

P304

166-177

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIM.12695

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

283

http://www.w3.org/2001/XMLSchema#string

P50

Behnam Sadeghi

L Volin

O Ringdén

P577

2017-11-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29027756

http://www.w3.org/2001/XMLSchema#string

P921

leukemia

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

about

P2860

P2860

What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease?

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P921